Recent & Archived News

Filter:

Bayer and Loxo Oncology to develop and commercialize two therapies that selectively target genetic drivers of cancer
» more
Bayer Announces BAY94-9027 Biologics License Application Accepted by U.S. Food & Drug Administration
» more
Bayer and the Society for Reproductive Investigation Collaborate to Advance Women's Healthcare Research
» more
Bayer Receives FDA Approval for Aliqopa™ (copanlisib) 60 mg vial for Injection in Adults with Relapsed Follicular Lymphoma after Two Prior Systemic Therapies
» more
Bayer to Highlight New Research at ESMO 2017 Congress
» more
Bayer announces enrollment of first U.S. patient in Phase III trials of vilaprisan in uterine fibroids
» more
Bayer Receives FDA Approval of myBETAapp™ and BETACONNECT Navigator™
» more
Bayer to Present Pulmonary Hypertension Data at the American Thoracic Society 2017 International Conference
» more
Bayer to Highlight Oncology Franchise Research at ASCO 2017
» more
Bayer Appoints Bhavesh Ashar to Lead U.S. Oncology Business
» more

Want even more Bayer news? Check out our Social Media & Blogs.